Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray

• Váldodahkkit: Heather Rozjabek (Dahkki), Nan Li (Dahkki), Holger Hartmann (Dahkki), Dong Jing Fu (Dahkki), Carla Canuso (Dahkki), Carol Jamieson (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SpringerOpen, 2022-07-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Major depressive disorder (MDD) directly impacts patients' lives including symptoms, functioning and health-related quality-of-life (HRQoL). Patient-reported outcomes can capture these impacts, however interpretation of clinical meaningfulness of these measurements are often...